Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDGSangeetha Iyer, Ethan Perlstein|Disease Models & Mechanisms|2019Cited by 78
Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDGSangeetha Iyer, Ethan Perlstein|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 32